Sign In

Andrew Chapman

Senior Director at AstraZeneca | Drug Delivery & Digital Health

Andrew Chapman is a Senior Director at AstraZeneca, a prominent pharmaceutical company.24 He works in the Biopharmaceutical Development division, where he leads technology strategy and oversees the evaluation of various projects.2

Professional Background

Andrew is known for his expertise in several areas:

  • Engineering: He holds a Bachelor's degree in Engineering (BEng).2
  • Business Administration: Chapman has also earned an MBA, indicating a strong foundation in management and business strategy.2
  • Drug Delivery and Digital Health: His current focus at AstraZeneca involves these cutting-edge areas of pharmaceutical development.3

Skills and Reputation

Andrew Chapman is highly regarded in his field:

  • Innovation: He is recognized as an extremely talented engineer and innovator.1
  • Project Management: Chapman is known for his ability to deliver projects on time and under budget.1
  • Leadership: As a Senior Director, he demonstrates strategic thinking and adaptive leadership skills.6
  • Experience: He brings over 19 years of experience in consulting and strategy leadership to his role.6

Areas of Expertise

At AstraZeneca, Andrew Chapman is involved in several key areas:

  • Connected Devices: He has shared insights on this topic through professional networks.3
  • Wearable Injectors: Chapman is a featured speaker at conferences discussing wearable injectors and connected devices in the pharmaceutical industry.5
  • Technology Strategy: In his role, he leads the technology strategy for biopharmaceutical development.2

Andrew Chapman's LinkedIn profile can be found under the username "andrew-chapman".1 His position at AstraZeneca and his involvement in various pharmaceutical conferences highlight his significant role in advancing drug delivery technologies and digital health solutions in the biopharmaceutical industry.

Highlights

Oct 10 · linkedin

Really enjoyed chairing the ‘Wearable Injectors and Connected Devices’ conference in London with Ian Wallace. Some excellent learnings were shared by our speakers along with some pretty frank panel discussions around all things digital and devices with a focus on patient centricity.

A special thank-you to... Julian Dixon and Caroline Zakrzewski for representing AstraZeneca (pictured) and Marie Picci, Cedric Gysel, Dr. Ingo Waschulewski, Richard Crowther, Thomas W. Møller, Paula Antunes, Simon Wilson, Sabine Kattenbeck, Graeme Davies  SAE Media Group Pharma #connecteddevices

Dec 10 · linkedin

Looking forward to tomorrow’s 'Accelerating Digital Health' stream at #Genesis2019. Also to meeting some old friends, new acquaintances and hearing the latest insights from:

Kath Mackay, Rowan Gardner, Mark Avery, Adam Collier, Harry Lamble, Michael Anstey, Jason Mellad, Hakim Yadi Ph.D. OBE, Oliver Sexton, Richard Erwin,Robert Docherty, Jonathan Green, Antoine Espinet, Neelam Patel, the list of UK life science superstars goes on.

Thanks in advance to the folks at One Nucleus for what I’m sure will be an excellent day!

#digitalhealth #lifescience #medtech #machinelearning #leadership

Related Questions

What are Andrew Chapman's main responsibilities at AstraZeneca?
How has Andrew Chapman contributed to AstraZeneca's technology strategy?
What projects has Andrew Chapman led at AstraZeneca?
What is Andrew Chapman's background before joining AstraZeneca?
How does Andrew Chapman's work impact drug delivery and digital health?
Andrew Chapman
Andrew Chapman, photo 1
Andrew Chapman, photo 2
Add to my network

Location

Greater Cambridge Area